Norgen Biotek Corp. Expands its Urine Sample Preparation Product Offering by Launching Novel Robust Urine DNA, RNA, microRNA, Proteins, Exfoliated Cells and Microorganisms Isolation Kits.

THORHOLD, ON, Jan. 6 /PRNewswire/ - Norgen Biotek Corp, a privately held Canadian biotechnology company focusing principally on advancing a powerful proprietary technology for application in sample preparation for nucleic acid (DNA, RNA and microRNA) and protein purification, today announced the expansion of its basket of urine-based sample preparation products. With the launch of the new products Norgen now has the largest basket of kits to preserve, concentrate and purify macromolecules such as DNA, RNA, microRNA, proteins, exfoliated cells and microorganisms from less than 1 milliliter up to 50 milliliters of urine.

These Kits provide a fast, robust, reliable and simple procedure for isolating high quality DNA, RNA, and microRNA suitable for molecular biology applications. The sensitivity and speed make these kits very useful and powerful tools for isolating high quality analytes from urine for applications not only in biomarker discovery and diagnosis but also in the monitoring of renal and other diseases. The preservative kit is convenient and very useful for preserving macromolecules during shipping at ambient temperature.

"Currently, we have more than 70 kits for genomics and proteomics research applications. Our mission is to bring to market innovative Best-in-Class sample preparation kits that can be used in research as well as in diagnostic applications. Indeed, since we became ISO certified we have been diligently working on adopting these cutting edge sample preparation tolls to develop First-In-Class non-invasive point-of-care diagnostic kits" Said Dr. Yousef Haj-Ahmad , President & CEO of Norgen Biotek.

About Norgen Biotek Corp.

Norgen Biotek is a rapidly growing privately-held Canadian biotechnology company specialized in the research, development, manufacture and marketing of a variety of commercial products derived from its proprietary technology. Currently, this technology is used in protein, RNA and DNA purification and clean-up kits. Norgen is also actively working on the adoption of this enabling technology into the diagnostic market as well as for industrial scale applications. We are actively seeking suitable channels to market as well as strategic partners.

Additional information is available on the Company's website: www.norgenbiotek.com

SOURCE Norgen Biotek Corp.